Key molecules in this space include semaglutide, liraglutide, dulaglutide, and orlistat, developed by companies like Novo Nordisk, Eli Lilly, and Roche
Progress in Biomaterials, 11 (3), 273280
Finally, we introduce the potential of L-cell differentiation as an attractive future therapeutic approach to increase GLP-1 production as an attractive therapeutic alternative for T2DM
It is reported that the GSH system plays an important role in maintaining redox homeostasis and thus supports cancer cells' survival in response to oxidative stress [29]
Once steady state is achieved, each new weekly injection adds fresh medication to existing levels, maintaining a therapeutic window throughout the seven-day period